Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Oct 31;9(3):1450.
doi: 10.4022/jafib.1450. eCollection 2016 Oct-Nov.

Management of Patients with Atrial Fibrillation: Focus on Treatment Options

Pawel Matusik  1   2 , Jacek Lelakowski  1   3 , Barbara Malecka  1   3 , Jacek Bednarek  1 , Remigiusz Noworolski  1
Affiliations
Review

Management of Patients with Atrial Fibrillation: Focus on Treatment Options

Pawel Matusik et al. J Atr Fibrillation. .

Abstract

Atrial fibrillation (AF) is leading cardiac arrhythmia with important clinical implications. Its diagnosis is usually made on the basis on 12-lead ECG or 24-hour Holter monitoring. More and more clinical evidence supports diagnostic use of cardiac event recorders and cardiovascular implantable electronic devices (CIED). Treatment options in patients with atrial fibrillation are extensive and are based on chosen rhythm and/or rate control strategy. The use and selected contraindications to AF related pharmacotherapy, including anticoagulants are shown. Nonpharmacological treatments, comorbidities and risk factors control remain mainstay in the treatment of patients with AF. Electrical cardioversion consists important choice in rhythm control strategy. Much progress has been made in the field of catheter ablation and cardiac surgery methods. Left atrial appendage occlusion/closure may be beneficial in patients with AF. CIED are used with clinical benefits in both, rhythm and rate control. Pacemakers, implantable cardioverter-defibrillators and cardiac resynchronization therapy devices with different pacing modes have guaranteed place in the treatment of patients with AF. On the other hand, the concepts of permanent leadless cardiac pacing, atrial dyssynchrony syndrome treatment and His-bundle or para-Hisian pacing have been proposed. This review summarizes and discusses current and novel treatment options in patients with atrial fibrillation.

Keywords: Ablation; Atrial Fibrillation; CRT; ICD; Pacemaker; Treatment.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Overview of clinical management of patients with atrial fibrillation
AF, atrial fibrillation; HF, heart failure; DDD, dual chamber pacemaker; ICD, implantable cardioverter-defibrillator; CRT-P/D, cardiac resynchronization therapy-pacemaker/defibrillator. ^ not recommended in left ventricular hypertrophy >15mm or ≥14mm (ibutilide) ^^ not for cardioversion. * some of these drugs should not be used in decompensated heart failure and/or in patients with pre-excitation
Figure 2.
Figure 2.. Overview of atrial fibrillation ablation indications
AF, atrial fibrillation
Figure 3.
Figure 3.. Overview of current options and/or guidelines recommendations for cardiovascular implantable electronic devices use in patients with AF. Based on,[57,58] other references are cited throughout the text
AV, atrioventricular; AVB, atrioventricular block; CIED, cardiovascular implantable electronic devices; EF, ejection fraction; NYHA, New York Heart Association; BiV, biventricular; other abbreviations as in Fig. 1
See this image and copyright information in PMC

References

    1. Chugh Sumeet S, Havmoeller Rasmus, Narayanan Kumar, Singh David, Rienstra Michiel, Benjamin Emelia J, Gillum Richard F, Kim Young-Hoon, McAnulty John H, Zheng Zhi-Jie, Forouzanfar Mohammad H, Naghavi Mohsen, Mensah George A, Ezzati Majid, Murray Christopher J L. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014 Feb 25;129 (8):837–47. - PMC - PubMed
    1. Kristensen Marie S, Zwisler Ann-Dorthe, Berg Selina K, Zangger Graziella, Grønset Charlotte N, Risom Signe S, Pedersen Susanne S, Oldridge Neil, Thygesen Lau C. Validating the HeartQoL questionnaire in patients with atrial fibrillation. Eur J Prev Cardiol. 2016 Sep;23 (14):1496–503. - PubMed
    1. Emdin Connor A, Wong Christopher X, Hsiao Allan J, Altman Douglas G, Peters Sanne Ae, Woodward Mark, Odutayo Ayodele A. Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies. BMJ. 2016 Jan 19;532 () - PMC - PubMed
    1. Dewland Thomas A, Vittinghoff Eric, Mandyam Mala C, Heckbert Susan R, Siscovick David S, Stein Phyllis K, Psaty Bruce M, Sotoodehnia Nona, Gottdiener John S, Marcus Gregory M. Atrial ectopy as a predictor of incident atrial fibrillation: a cohort study. Ann. Intern. Med. 2013 Dec 03;159 (11):721–8. - PMC - PubMed
    1. Stein Phyllis K. Increased randomness of heart rate could explain increased heart rate variability preceding onset of atrial fibrillation. J. Am. Coll. Cardiol. 2004 Aug 04;44 (3):668–9. - PubMed

LinkOut - more resources